C7 and neuroblastoma: In summary, transcriptomic expression of the C7 gene was previously identified as a risk factor for AD (Song et al., 2012), whereas ZYX was known to be degraded by Aβ peptides in the neuroblastoma cell model (Lanni et al., 2013).